IDH2 and central nervous system cancer: The situation is further complicated by the fact that IDH mutations in gliomas are almost always heterozygous, which means that tumor cells are likely to contain both mutant homodimers and mutant/wildtype heterodimers, the exact ratio of which has not been established [4,108].